Earnings History Data for Homology Medicines, Inc. (FIXX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Homology Medicines, Inc.

Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2023	AH		FIXX	Homology Medicines	58.00	-0.57	-0.42	0.00	Homology Medicines GAAP EPS of -$0.57 misses by $0.15 [11/14/2023 5:58 PM]	0.8799	-0.14 (-13.74%)	0.97	-0.05 (-4.90%)	0.80 - 2.29	906,493	220,000	30,343
Homology Medicines GAAP EPS of -$0.57 misses by $0.15 [11/14/2023 5:58 PM]
14-08-2023	AH		FIXX	Homology Medicines	69.00	-0.61	-0.51	0.00	Homology Medicines GAAP EPS of -$0.61, revenue of $0.35M [8/14/2023 5:07 PM]	1.20	0.02 (1.69%)	1.16	-0.02 (-1.69%)	0.80 - 3.30	269,265	240,000	1,316
Homology Medicines GAAP EPS of -$0.61, revenue of $0.35M [8/14/2023 5:07 PM]
11-05-2023	AH		FIXX	Homology Medicines	59.00	-0.50	-0.55	0.00	Homology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21M [5/11/2023 5:20 PM]	1.00	0.0 (0.00%)	1.00	0.0 (0.00%)	0.86 - 3.30	134,189	90,000	782
Homology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21M [5/11/2023 5:20 PM]
09-03-2023	AH	4:05 PM ET (Mar 9)	FIXX	Homology Medicines	87.00	-0.60	-0.51	0.00	Homology Medicines GAAP EPS of -$0.60 misses by $0.07, revenue of $0.82M misses by $0.1M [3/9/2023 5:55 PM]	1.24	-0.10 (-7.84%)	1.32	-0.02 (-1.49%)	1.04 - 3.57	482,021	130,000	4,258
Homology Medicines GAAP EPS of -$0.60 misses by $0.07, revenue of $0.82M misses by $0.1M [3/9/2023 5:55 PM] Homology Medicines gets new chief medical officer [3/9/2023 8:37 AM]
10-11-2022	AH		FIXX	Homology Medicines	80.00	-0.59	-0.47	0.00	Homology Medicines GAAP EPS of -$0.59 misses by $0.11, revenue of $0.80M misses by $0.16M [11/10/2022 5:52 PM]	1.50	0.09 (6.38%)	1.34	-0.07 (-4.96%)	1.30 - 6.02	181,297	100,000	4,334
Homology Medicines GAAP EPS of -$0.59 misses by $0.11, revenue of $0.80M misses by $0.16M [11/10/2022 5:52 PM] Homology Medicines Reports Third Quarter 2022 Financial Results and Recent Highlights [Nov-10-22 04:07PM]
15-08-2022	AH		FIXX	Homology Medicines	164.00	-0.51	-0.57	0.00	Homology Medicines GAAP EPS of -$0.51 beats by $0.04, revenue of $0.8M misses by $0.31M [8/15/2022 5:31 PM]	2.89	0.0 (0.00%)	3.19	0.30 (10.38%)	1.30 - 8.90	169,884	230,000	1,262
Homology Medicines GAAP EPS of -$0.51 beats by $0.04, revenue of $0.8M misses by $0.31M [8/15/2022 5:31 PM] Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and Provides Business Update [Aug-15-22 04:10PM] Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder [Aug-12-22 07:46AM]
16-05-2022	AH		FIXX	Homology Medicines	90.00	-0.20	-0.25	0.00	Homology Medicines GAAP EPS of $1.59 beats by $1.52 [5/16/2022 4:39 PM]	1.53	0.10 (6.60%)	1.44	0.0 (0.00%)	1.39 - 8.90	421,379	400,000	15,579
Homology Medicines GAAP EPS of $1.59 beats by $1.52 [5/16/2022 4:39 PM] Homology Medicines Reports First Quarter 2022 Financial Results and Recent Highlights [May-16-22 04:15PM] SolGel Technologies Ltd. (SLGL) Reports Q1 Loss, Misses Revenue Estimates [May-13-22 08:45AM] Homology Medicines (FIXX) Reports Q1 Loss, Misses Revenue Estimates [May-16-22 06:05PM]
23-03-2022	AH		FIXX	Homology Medicines	192.00	-0.59	-0.58	0.00	Homology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1M [3/23/2022 5:30 PM]	3.20	-0.06 (-1.69%)	3.30	0.04 (1.23%)	2.54 - 9.83	342,323	608,090	503
Homology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1M [3/23/2022 5:30 PM] Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights [Mar-23-22 04:10PM] Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates [Mar-23-22 05:45PM]
12-08-2021	AH		FIXX	Homology Medicines, Inc.	384.00	-0.54	-0.58	0.00	Homology Medicines EPS beats by $0.06, beats on revenue [8/12/2021 4:59 PM]	6.92	0.07 (1.02%)	6.85	0.0 (0.00%)	5.94 - 15.24	365,625	320,000	19,724
Homology Medicines EPS beats by $0.06, beats on revenue [8/12/2021 4:59 PM] Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights [Aug-12-21 04:05PM] Homology Medicines (FIXX) Reports Q2 Loss, Tops Revenue Estimates [Aug-12-21 07:05PM]
06-05-2021	AH		FIXX	Homology Medicines, Inc.	367.62	-0.02	-0.65	-0.78	Homology Medicines EPS beats by $0.62, beats on revenue [5/6/2021 5:11 PM]	6.51	0.25 (3.99%)	6.53	0.27 (4.31%)	6.08 - 17.34	506,929	590,000	1,792
Homology Medicines EPS beats by $0.62, beats on revenue [5/6/2021 5:11 PM] Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights [May-06-21 04:05PM] Homology Medicines (FIXX) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 06:15PM]
09-11-2020	AH		FIXX	Homology Medicines, Inc.	542.62	-0.62	-0.81	-0.67	Homology Medicines EPS beats by $0.18, beats on revenue [11/9/2020 4:51 PM]	9.64	-0.24 (-2.38%)	10.15	0.28 (2.84%)	9.19 - 22.50	492,453	614,820	3,377